Author

Abdelillah Maarad

InsermORCID 0009-0002-9331-3753Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Ana Carolina Bastos Sant'Anna SilvaiD· 1 shared Ari M. MelnickiD· 1 shared Arnaud JacqueliD· 1 shared Calixte CalaudiD· 1 shared Coralie F DupontiD· 1 shared Corinne MénigotiD· 1 shared David YoannidisiD· 1 shared Emeline KerreneuriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana Carolina Bastos Sant'Anna SilvaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhanced efficacy of a specific HDAC3 inhibitor in combination with 5-Azacitidine against diffuse large B-cell lymphoma

Calixte Calaud, Emilio M. Serrano-López, Leonie A. Cluse, Izabela Todorovski, Thomas Mardivirin, Matt R. Teater, Abdelillah Maarad, Noura Tawfic, Peter Fraser, Killian Guiraud, Coralie F Dupont, Corinne Ménigot, Ana Carolina Bastos Sant'Anna Silva, David Yoannidis, Timothy J. Semple, , Pilar M. Domínguez

This study shows that combining a HDAC3 inhibitor with 5-Azacitidine enhances anti-tumor effects against DLBCL in vitro and in vivo, with reduced toxicity compared to single agents.

Blood Neoplasia · Mar 2, 2026Peer-reviewedCancer Biology